SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
The Epstein Family Foundation has granted Sanford Burnham Prebys Medical Discovery Institute $1 million to pursue pancreatic and prostate cancer research.
PatientSafe Solutions Inc. this month reported selling nearly $4.5 million in notes convertible to preferred stock in the San Diego-based health-care information technology company.
San Diego drugmaker Arena Pharmaceuticals Inc. announced that Vincent Aurentz is joining the company as executive vice president and chief business officer, effective today.
The former chief medical officer of pharmaceutical giant Celgene Corp., Dr. Jerome Zeldis, is joining San Diego’s Sorrento Therapeutics Inc. as its new chief medical officer and president of clinical development.
Faheem Hasnain, a well-respected biotech executive, has been appointed to Vital Therapies Inc.’s board of directors.
San Diego’s early-stage life science companies are invited to apply for CapitalMatch, a program run by San Diego startup accelerator Connect to link companies seeking funding with interested investors.
Federal prosecutors have charged two San Diego businessmen with insider trading for using a confidential tip to snag $83,000 in profit when local biotech Ardea Biosciences was acquired in 2012.
Halozyme Therapeutics Inc. bumped its estimate for this year’s total net revenue haul to a high of $150 million, according to a recent financial statement.
Biocept Inc. struck a deal with life science distributor HarlePhil Venture Inc. to get Biocept’s liquid biopsy tests into the Philippines market.
Kura Oncology stock is trading sharply higher this morning after revealing the results of a Phase 2 trial of one of its cancer drugs, Tipifarnib.
Medtech giant Illumina Inc. announced a partnership with Oregon-based tech firm FlowJo LLC to develop and co-market software for analyzing single-cell, next-generation sequencing data.
San Diego drugmaker Acadia Pharmaceuticals Inc. is looking to raise $200 million in a secondary offering.
Scintilla Pharmaceuticals Inc., a subsidiary of San Diego’s Sorrento Therapeutics Inc., is acquiring a Pennsylvania-based pharmaceutical company focused on pain management.
San Diego biotech MEI Pharma signed a major deal with Swiss pharmaceutical group Helsinn that could be worth up to $464 million.
San Diego’s Orexigen Therapeutics Inc. reported a jump in quarterly revenue, but missed Wall Street’s expectations for total earnings-per-share, according to a recent earnings statement.